Imidazolylsulfonates: Electrophilic partners in cross-coupling reactions

Organic Letters

Volumn 11, Issue 7, 2009, Pages 1463-1466

  Albaneze Walker, Jennifer ^a   Raju, Ravinder ^a   Vance, Jennifer A ^a   Goodman, Andrew J ^a   Reeder, Michael R ^a   Liao, Jing ^a   Maust, Mathew T ^a   Irish, Patrick A ^a   Espino, Peter ^a   Andrews, David R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLSULFONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; MESYLIC ACID DERIVATIVE; PALLADIUM;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY;

ARYLSULFONATES; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; IMIDAZOLES; MESYLATES; MOLECULAR STRUCTURE; PALLADIUM;

EID: 64349108740     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol802381k     Document Type: Article

References (53)

1. (a) Scott, W.; Crisp, G.; Stille, J. K. J. Am. Chem. Soc. 1984, 106, 4630-4632.
2. (b) For a review of triflate chemsitry, see: Baraznenok, I.; Nenajdenko, V.; Balenkova, E. Tetrahedron 2000, 56, 3077-3119.
3. (c) For a review of heterocycle synthesis via cross-coupling of triflates, see: Gilson, Z.; Larock, R. Chem. Rev. 2006, 106, 4644-4680.
4. (a) Roy, A.; Hartwig, J. J. Am. Chem. Soc. 2003, 125, 8704-8705.
5. (b) Nguyen, H.; Huang, X.; Buchwald, S. J. Am. Chem. Soc. 2003, 125, 11818-11819.
6. (c) Zhang, L.; Meng, T.; Wu, J. J. Org. Chem. 2007, 72, 9346-9349.
7. (d) Steinhuebel, D.; Baxter, J.; Palucki, M.; Davies, I. J. Org. Chem. 2005, 70, 10124-10127.
8. (e) Baxter, J.; Steinhuebel, D.; Palucki, M.; Davies, I. Org. Lett. 2005, 7, 215-218.
9. (f) Wu, J.; Zhu, Q.; Fathi, R.; Yang, Z. J. Org. Chem. 2003, 68, 670-673.
10. (g) Molander, G.; Yun, C. Tetrahedron 2002, 58, 1465-1470.
11. (h) Ackermann, L.; Althammer, A. Org. Lett. 2006, 8, 3457-3460.
12. (i) Huffman, M.; Yasuda, N. Synlett 1999, 471-473.
13. (j) For an example of Sonogashira coupling of a vinyl tosylate, see: Woo, J.; Walker, S.; Faul, M. Tetrahedron Lett. 2007, 48, 5679-5682.
14. (k) Fu, X.; Zhang, S.; Yin, J.; Schumacher, D. Tetrahedron Lett. 2002, 43, 6673-6676.
15. (l) For reductive deoxygenation of aryl mesylate, see: Sajiki, H.; Mori, A.; Mizusaki, T.; Ikawa, T.; Maegawa, T.; Hirota, K. Org. Lett. 2006, 8, 987-990.
16. (m) For an amination of mesylates, see: So, C.; Zhou, Z.; Lau, C.; Kwong, F. Angew. Chem., Int. Ed. 2008, 47, 1-6.
17. (a) Hanessian, S.; Vatèle, J.-M. Tetrahedron Lett. 1981, 37, 3579-3582.
18. (b) Vatele, J.-M.; Hanessian, S. Tetrahedron 1996, 52, 10557-10568, and references therein.
19. (a) Ingram, L.; Taylor, S. Angew. Chem., Int. Ed. 2006, 45, 3503-3506.
20. (b) Beaudion, S.; Kinsey, K.; Burns, J. J. Org. Chem. 2003, 68, 115-119.
21. (c) Ma, T.; Pai, B.; Zhu, Y.; Lin, J.; Shanmuganathan, K.; Du, J.; Wang, C.; Kim, H.; Newton, M.; Cheng, Y.; Chu, C. J. Med. Chem. 1996, 39, 2835-2843.
22. (d) Ahmed, F.; David, S.; Vatèle, J.-M. Carbohydr. Res. 1986, 155, 19-31.
23. (e) David, S.; Malleron, A.; Dini, C. Carbohydr. Res. 1989, 158, 193-200.
24. (e) Duan, S.; Binkley, E.; Binkley, R. J. Carbohydr. Chem. 1998, 17, 391-396.
25. (f) Tann, C.; Brodfuehrer, P.; Brundidge, S.; Sapino, C.; Howell, H. J. Org. Chem. 1985, 50, 3644-3647.
26. (g) Chou, T.; Becke, L.; O'Toole, J.; Carr, M.; Parker, J Tetrahedron Lett. 1996, 37, 17-20.
27. (h) Alais, J; David, S. Carbohydr. Res. 1992, 230, 79-87.
28. (i) Best, W.; Macdonald, J.; Skelton, B.; Stick, R.; Tilbrook, D.; White, A. Can. J. Chem. 2002, 80, 857-865.
29. (j) Meloncelli, P.; Stick, R. Aust. J. Chem. 2006, 59, 827-833.
30. (a) Teranishi, K.; Hisamatsu, M.; Yamada, T. Tetrahedron Lett. 2000, 41, 933-936.
31. (b) Fevig, T.; Mao, M.; Katzenellenbogen, J. Steroids 1988, 51, 471-479.
32. (d) Ahmed, F.; David, S.; Vatele, J.-M. Carbohydr. Res. 1986, 155, 19-31.
33. Goddard-Borger, E.; Stick, R. Org. Lett. 2007, 9, 3797-3800.
34. (a) Staab, H.; Wendel, K. Angew. Chem. 1961, 73, 26.
35. (b) Staab, H; Wendel, K. J. Liebigs Ann. Chem. 1966, 694, 86-90.
36. (c) 1,1'-Sulfonyldiimidazole has been used recently as an imidazole transfer reagent; see: Keith, J. J. Org. Chem. 2008, 73, 327-330.
37. (a) For recent reviews of the Suzuki-Miyaura coupling reaction see: Doucet, H. Eur. J. Org. Chem. 2008, 7, 1133-1155 and
38. (b) Alonso, F.; Beletskaya, I.; Yus, M. Tetrahedron 2008, 64, 3047-3101.
39. (c) For a recent review of Negishi couplings, see: Negishi, E.-I. Bull. Chem. Soc. Jpn. 2007, 80, 233-257.
40. (d) Reeder, M.; Gleaves, H.; Hoover, S.; Imbordino, R. Pangborn. J. Org. Proc. Res. Dev.. 2003, 7, 696-699.
41. (e) Anderson, B.; Becke, L.; Booher, R.; Flaugh, M.; Harn, N.; Kress, T.; Varie, D.; Wepsiec, J. J. Org. Chem. 1997, 62, 8364-8369.
42. (f) Anderson, B.; Harn, N. Synthesis 1996, 5, 583-585.
43. (g) Crowe, E.; Hossner, F.; Hughes, M. Tetrahedron 1995, 51, 8889-8890.
44. (a) Scott, W.; Stille, J. K. J. Am. Chem. Soc. 1986,108, 3033-3040.
45. (b) Echavarren, A.; Stille, J. K. J. Am. Chem. Soc. 1987, 109, 5478-5486.
46. (c) Casado, A.; Espinet, P.; Gallego, A. J. Am. Chem. Soc. 2000, 122, 11771-11782.
47. Albaneze-Walker, J.; Bazaral, C.; Leavey, T.; Dormer, P.; Murry, J. Org. Lett. 2004, 6, 2097-2100.
48. (a) Elder, D.; Teasdale, A.; Lipczynski, A. J. Pharm. Biomed. Anal. 2008, 46, 1-8.
49. (b) Snodin, D. Reg. Toxicol. Pharm. 2006, 45, 79-90.
50. (c) Glowienke, S.; Frieauff, W.; Allmendinger, T.; Martus, H.-J.; Mueller, L. Mutat. Res. 2005, 581, 23-34.
51. (d) Committee for Medicinal Products (CHMP); Guideline on the Limits of Genotoxic Impurities; European Medicines Agency: London, 2008 (CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006).
52. (a) Staab, H. Angew. Chem.mInt. Ed. Engl. 1962, 1, 351-367.
53. (b) Botchkavvieva, T; Passet, B. Zh. Obshch. Khim. 1983, 2221-2222.